These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Human papillomavirus E6 and Myc proteins associate in vivo and bind to and cooperatively activate the telomerase reverse transcriptase promoter. Veldman T; Liu X; Yuan H; Schlegel R Proc Natl Acad Sci U S A; 2003 Jul; 100(14):8211-6. PubMed ID: 12821782 [TBL] [Abstract][Full Text] [Related]
27. Human papillomavirus type 16 E6 activates TERT gene transcription through induction of c-Myc and release of USF-mediated repression. McMurray HR; McCance DJ J Virol; 2003 Sep; 77(18):9852-61. PubMed ID: 12941894 [TBL] [Abstract][Full Text] [Related]
28. Mechanisms of c-myc degradation by nickel compounds and hypoxia. Li Q; Kluz T; Sun H; Costa M PLoS One; 2009 Dec; 4(12):e8531. PubMed ID: 20046830 [TBL] [Abstract][Full Text] [Related]
29. Regulation of human telomerase activity: repression by normal chromosome 3 abolishes nuclear telomerase reverse transcriptase transcripts but does not affect c-Myc activity. Ducrest AL; Amacker M; Mathieu YD; Cuthbert AP; Trott DA; Newbold RF; Nabholz M; Lingner J Cancer Res; 2001 Oct; 61(20):7594-602. PubMed ID: 11606399 [TBL] [Abstract][Full Text] [Related]
30. Feedback regulation of telomerase reverse transcriptase: new insight into the evolving field of telomerase in cancer. Wu XQ; Huang C; He X; Tian YY; Zhou DX; He Y; Liu XH; Li J Cell Signal; 2013 Dec; 25(12):2462-8. PubMed ID: 23993966 [TBL] [Abstract][Full Text] [Related]
31. MCAF1/AM is involved in Sp1-mediated maintenance of cancer-associated telomerase activity. Liu L; Ishihara K; Ichimura T; Fujita N; Hino S; Tomita S; Watanabe S; Saitoh N; Ito T; Nakao M J Biol Chem; 2009 Feb; 284(8):5165-74. PubMed ID: 19106100 [TBL] [Abstract][Full Text] [Related]
33. Ad-mTERT-delta19, a conditional replication-competent adenovirus driven by the human telomerase promoter, selectively replicates in and elicits cytopathic effect in a cancer cell-specific manner. Kim E; Kim JH; Shin HY; Lee H; Yang JM; Kim J; Sohn JH; Kim H; Yun CO Hum Gene Ther; 2003 Oct; 14(15):1415-28. PubMed ID: 14577922 [TBL] [Abstract][Full Text] [Related]
34. Mechanisms of TERT Reactivation and Its Interaction with BRAFV600E. Song YS; Park YJ Endocrinol Metab (Seoul); 2020 Sep; 35(3):515-525. PubMed ID: 32981294 [TBL] [Abstract][Full Text] [Related]
35. Functional Loss of Graham MK; Kim J; Da J; Brosnan-Cashman JA; Rizzo A; Baena Del Valle JA; Chia L; Rubenstein M; Davis C; Zheng Q; Cope L; Considine M; Haffner MC; De Marzo AM; Meeker AK; Heaphy CM Mol Cancer Res; 2019 Dec; 17(12):2480-2491. PubMed ID: 31611308 [TBL] [Abstract][Full Text] [Related]
36. Derepression of hTERT gene expression promotes escape from oncogene-induced cellular senescence. Patel PL; Suram A; Mirani N; Bischof O; Herbig U Proc Natl Acad Sci U S A; 2016 Aug; 113(34):E5024-33. PubMed ID: 27503890 [TBL] [Abstract][Full Text] [Related]
38. Butylidenephthalide suppresses human telomerase reverse transcriptase (TERT) in human glioblastomas. Lin PC; Lin SZ; Chen YL; Chang JS; Ho LI; Liu PY; Chang LF; Harn YC; Chen SP; Sun LY; Huang PC; Chein JT; Tsai CH; Chou CW; Harn HJ; Chiou TW Ann Surg Oncol; 2011 Nov; 18(12):3514-27. PubMed ID: 21553143 [TBL] [Abstract][Full Text] [Related]
39. Regulation of c-MYC transcriptional activity by transforming growth factor-beta 1-stimulated clone 22. Zheng L; Suzuki H; Nakajo Y; Nakano A; Kato M Cancer Sci; 2018 Feb; 109(2):395-402. PubMed ID: 29224245 [TBL] [Abstract][Full Text] [Related]
40. Noncanonical functions of telomerase: implications in telomerase-targeted cancer therapies. Li Y; Tergaonkar V Cancer Res; 2014 Mar; 74(6):1639-44. PubMed ID: 24599132 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]